Quick Takeaways
- Terrie Curran has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $2,645,210.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Terrie Curran and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| PHAT | Phathom Pharmaceuticals, Inc. | President and Chief Executive, Director | $2,399,933 | 27 Feb 2025 | ||
| ARQT | Arcutis Biotherapeutics, Inc. | Director | $245,277 | 12 Jun 2025 | ||
| MYOV | Myovant Sciences Ltd. | Director | 10 Mar 2023 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|